Literature DB >> 20827781

Alpha₁-antitrypsin deficiency-related alleles Z and S and the risk of Wegener's granulomatosis.

Alfred D Mahr1, Jeffrey C Edberg, John H Stone, Gary S Hoffman, E William St Clair, Ulrich Specks, Paul F Dellaripa, Philip Seo, Robert F Spiera, Farshid N Rouhani, Mark L Brantly, Peter A Merkel.   

Abstract

OBJECTIVE: Deficiency of α(1) -antitrypsin (α(1) AT) may be a determinant of susceptibility to Wegener's granulomatosis (WG). Several previous, mainly small, case-control studies have shown that 5-27% of patients with WG carried the α(1) AT deficiency Z allele. It is not clear whether the S allele, the other major α(1) AT deficiency variant, is associated with WG. This study investigated the relationship of the α(1) AT deficiency Z and S alleles with the risk of developing WG in a large cohort.
METHODS: We studied the distribution of the α(1) AT deficiency alleles Z and S in 433 unrelated Caucasian patients with WG and 421 ethnically matched controls. Genotyping was performed using an allele discrimination assay. Results were compared between cases and controls using exact statistical methods.
RESULTS: Among the patients with WG, the allele carriage frequencies of Z and S were 7.4% and 11.5%, respectively. The frequencies of the 6 possible genotypes differed in a statistically significant manner between cases and controls (P = 0.01). The general genetic 2-parameter codominant model provided the best fit to the data. Compared with the normal MM genotype, the odds ratio (OR) for MZ or MS genotypes was 1.47 (95% confidence interval [95% CI] 0.98-2.22), and the OR for ZZ, SS, or SZ genotypes was 14.58 (95% CI 2.33-∞). ORs of similar direction and magnitude were observed within the restricted cohorts that excluded cases and controls carrying ≥1 Z or ≥1 S allele.
CONCLUSION: Both Z and S alleles display associations with risk of WG in a codominant genetic pattern. These findings strengthen the evidence of a causal link between α(1) AT deficiency and susceptibility to WG.
Copyright © 2010 by the American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20827781      PMCID: PMC3123032          DOI: 10.1002/art.27742

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  24 in total

1.  A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS).

Authors:  J H Stone; G S Hoffman; P A Merkel; Y I Min; M L Uhlfelder; D B Hellmann; U Specks; N B Allen; J C Davis; R F Spiera; L H Calabrese; F M Wigley; N Maiden; R M Valente; J L Niles; K H Fye; J W McCune; E W St Clair; R A Luqmani
Journal:  Arthritis Rheum       Date:  2001-04

2.  alpha 1-Antitrypsin (AAT) deficiency and ANCA-positive systemic vasculitis: genetic and clinical implications.

Authors:  F Callea; G Gregorini; A Sinico; G G Consalez; G Gonzales; M Bossolasco; G Salvidio; A Radice; P Tira; G Candiano; G Rossi; A Petti; G Ravera; G Ghiggeri; R Gusmano
Journal:  Eur J Clin Invest       Date:  1997-08       Impact factor: 4.686

Review 3.  Genetic associations: false or true?

Authors:  John P A Ioannidis
Journal:  Trends Mol Med       Date:  2003-04       Impact factor: 11.951

Review 4.  Antineutrophil cytoplasmic antibodies.

Authors:  Xavier Bosch; Antonio Guilabert; Josep Font
Journal:  Lancet       Date:  2006-07-29       Impact factor: 79.321

5.  C-antineutrophil cytoplasmic antibody positivity in vasculitis patients is associated with the Z allele of alpha-1-antitrypsin, and P-antineutrophil cytoplasmic antibody positivity with the S allele.

Authors:  M E Griffith; J U Lovegrove; G Gaskin; D B Whitehouse; C D Pusey
Journal:  Nephrol Dial Transplant       Date:  1996-03       Impact factor: 5.992

6.  Alpha 1-antitrypsin phenotypes in patients with anti-neutrophil cytoplasmic antibody-positive vasculitis.

Authors:  K Lhotta; W Vogel; T Meisl; M Buxbaum; U Neyer; C Sandholzer; P König
Journal:  Clin Sci (Lond)       Date:  1994-12       Impact factor: 6.124

7.  Real time PCR detection of the PI*Z and PI*S mutations associated with alpha-1 antitrypsin deficiency.

Authors:  Claudine L Bartels; Angela L Marchetti; W Edward Highsmith; Gregory J Tsongalis
Journal:  Am J Transl Res       Date:  2009-08-10       Impact factor: 4.060

Review 8.  Alpha1-antitrypsin deficiency. 1: epidemiology of alpha1-antitrypsin deficiency.

Authors:  M Luisetti; N Seersholm
Journal:  Thorax       Date:  2004-02       Impact factor: 9.139

9.  Genetic epidemiology of alpha-1 antitrypsin deficiency in North America and Australia/New Zealand: Australia, Canada, New Zealand and the United States of America.

Authors:  F J de Serres; I Blanco; E Fernández-Bustillo
Journal:  Clin Genet       Date:  2003-11       Impact factor: 4.438

10.  Alpha 1-antitrypsin deficiency and anti-proteinase 3 antibodies in anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis.

Authors:  J A Savige; L Chang; L Cook; J Burdon; M Daskalakis; J Doery
Journal:  Clin Exp Immunol       Date:  1995-05       Impact factor: 4.330

View more
  31 in total

1.  Meta-analysis of genetic polymorphisms in granulomatosis with polyangiitis (Wegener's) reveals shared susceptibility loci with rheumatoid arthritis.

Authors:  Sharon A Chung; Gang Xie; Delnaz Roshandel; Richard Sherva; Jeffrey C Edberg; Megan Kravitz; Paul F Dellaripa; Gary S Hoffman; Alfred D Mahr; Philip Seo; Ulrich Specks; Robert F Spiera; E William St Clair; John H Stone; Robert M Plenge; Katherine A Siminovitch; Peter A Merkel; Paul A Monach
Journal:  Arthritis Rheum       Date:  2012-10

Review 2.  Pathogenesis of ANCA-associated vasculitis.

Authors:  Rodrigo Cartin-Ceba; Tobias Peikert; Ulrich Specks
Journal:  Curr Rheumatol Rep       Date:  2012-12       Impact factor: 4.592

Review 3.  Endothelium-neutrophil interactions in ANCA-associated diseases.

Authors:  Lise Halbwachs; Philippe Lesavre
Journal:  J Am Soc Nephrol       Date:  2012-09       Impact factor: 10.121

Review 4.  Genetics of ANCA-associated Vasculitides.

Authors:  Manuel F Ugarte-Gil; Luis R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2014-07       Impact factor: 4.592

5.  Rare case of eosinophilic granulomatosis with polyangiitis in two patients with α-1-antitrypsin deficiency (PiSZ).

Authors:  Jordan Maureen Moxey; Emma Victoria Low; Alice Margaret Turner
Journal:  BMJ Case Rep       Date:  2016-04-26

Review 6.  The Diagnosis and Management of Alpha-1 Antitrypsin Deficiency in the Adult.

Authors:  Robert A Sandhaus; Gerard Turino; Mark L Brantly; Michael Campos; Carroll E Cross; Kenneth Goodman; D Kyle Hogarth; Shandra L Knight; James M Stocks; James K Stoller; Charlie Strange; Jeffrey Teckman
Journal:  Chronic Obstr Pulm Dis       Date:  2016-06-06

Review 7.  Pathogenesis of ANCA-associated vasculitis.

Authors:  Julia Flint; Matthew D Morgan; Caroline O S Savage
Journal:  Rheum Dis Clin North Am       Date:  2010-06-23       Impact factor: 2.670

8.  [Genetic risk factors for vasculitis].

Authors:  J U Holle; W L Gross
Journal:  Internist (Berl)       Date:  2014-02       Impact factor: 0.743

Review 9.  ANCA-associated vasculitis - clinical utility of using ANCA specificity to classify patients.

Authors:  Divi Cornec; Emilie Cornec-Le Gall; Fernando C Fervenza; Ulrich Specks
Journal:  Nat Rev Rheumatol       Date:  2016-07-28       Impact factor: 20.543

10.  Association of ETS1 polymorphism with granulomatosis with polyangiitis and proteinase 3-anti-neutrophil cytoplasmic antibody positive vasculitis in a Japanese population.

Authors:  Aya Kawasaki; Keita Yamashita; Fumio Hirano; Ken-Ei Sada; Daisuke Tsukui; Yuya Kondo; Yoshitaka Kimura; Kurumi Asako; Shigeto Kobayashi; Hidehiro Yamada; Hiroshi Furukawa; Kenji Nagasaka; Takahiko Sugihara; Kunihiro Yamagata; Takayuki Sumida; Shigeto Tohma; Hajime Kono; Shoichi Ozaki; Seiichi Matsuo; Hiroshi Hashimoto; Hirofumi Makino; Yoshihiro Arimura; Masayoshi Harigai; Naoyuki Tsuchiya
Journal:  J Hum Genet       Date:  2017-10-05       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.